Marketing approvals for cell and gene therapy products in oncology: Current review of EMA and FDA approvals. Vehicle 1 Doxorubicin HSP90 Inhibitor 1 Doxorubicin+HSP90 Inhibitors 1 Vehicle 2 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results